Recombinant factor VIIa enhances platelet adhesion and activation under flow conditions at normal and reduced platelet count

This publication has 48 references indexed in Scilit:

• Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trial
  The Lancet, 2003
• Ability of Recombinant Factor VIIa to Reverse the Anticoagulant Effect of the Pentasaccharide Fondaparinux in Healthy Volunteers
  Circulation, 2002
• Safety and efficacy of recombinant factor VIIa in patients with liver disease undergoing laparoscopic liver biopsy
  Gastroenterology, 2002
• Use of recombinant factor VIIa (NovoSeven®) in patients with Glanzmann thrombasthenia
  Seminars in Hematology, 2001
• Recombinant Activated Factor VII for Adjunctive Hemorrhage Control in Trauma
  Published by Wolters Kluwer Health ,2001
• Successful treatment with recombinant factor VIIa of therapy‐resistant severe bleeding in a patient with acquired von Willebrand disease
  American Journal of Hematology, 2001
• REDUCED TRANSFUSION REQUIREMENTS BY RECOMBINANT FACTOR VIIa IN ORTHOTOPIC LIVER TRANSPLANTATION
  Transplantation, 2001
• Treatment of Patients with Factor VIII and Factor IX Inhibitors with Special Focus on the Use of Recombinant Factor VIIa
  Thrombosis and Haemostasis, 1999
• The effect of recombinant factor VIIa (NovoSeven???) in healthy volunteers receiving acenocoumarol to an International Normalized Ratio above 2.0
  Blood Coagulation & Fibrinolysis, 1998
• Treatment of a Patient with Bernard-Soulier Syndrome and Recurrent Nosebleeds with Recombinant Factor VIIa
  Thrombosis and Haemostasis, 1998